When analyzing the association between CD276 expression and tumor stage by immunohistochemistry in sample subsets, the highest median scores were observed in T2b and T3a tumors, followed by a minor, non-significant decline in higher stages (T3b and T4). This evidence concerns the gene CD276 and neoplasm.